Novartis to purchase British biotech Gyroscope, a gene-therapy company
December 22, 2021 at 08:10 AM EST
The deal for Gyroscope is Novartis’s first acquisition since it agreed to sell a large stake in Roche back to its crosstown rival for $20.7 billion.
